Valerie van Dam

6PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 09, 2021
A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab.

Gil Awada, Yanina Jansen, Julia Katharina Schwarze

|Jun 20, 2020
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.

Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida

|Nov 06, 2019
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.

Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida

|Sep 14, 2018
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.

Bram De Laere, Steffi Oeyen, Markus Mayrhofer

Pageof 1

Frequent Collaborators

3 joint publications

Joy S Tea

3 joint publications

Aaron Prendergast

3 joint publications

Maria Jose Mendez

3 joint publications

Thomas Powles